PhD Trials® strengthens its growth with the acquisition of Inovapotek

Marking its 15th anniversary, PhD Trials® takes a new step forward by integrating the second-largest Portuguese company specializing in clinical studies and testing. This move aligns with an expansion strategy focused on team development, technological investment, and meeting evolving scientific and regulatory requirements.

With nearly two decades of expertise, Inovapotek will retain its leadership under Dr. Marta Ferreira. The integration is expected to create strong technical synergies and expand capabilities in clinical research and product performance evaluation, reinforcing the group’s commitment to sustainable growth.